17.75
price down icon1.93%   -0.35
after-market Dopo l'orario di chiusura: 16.87 -0.88 -4.96%
loading

Travere Therapeutics Inc Azioni (TVTX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
8.18%
41.37
45.06 37.09 32.20 30.89
Cost Of Revenue
67.05%
1.504
4.564 1.289 1.99 5.125
Gross Profit
1.54%
39.87
40.49 35.81 57.71 51.87
Operating Expenses
28.58%
179.11
139.29 129.68 136.15 128.26
Interest Income/Expense
0.00%
2.80
2.80 2.80 2.90 2.90
Benefits Costs and Expenses
32.60%
177.14
133.59 126.32 134.06 127.37
Costs And Expenses
29.66%
180.61
139.29 129.68 136.15 128.26
Operating Income/Loss
47.76%
-139.24
-94.23 -92.58 -103.95 -97.37
Nonoperating Income/Loss
39.18%
3.47
5.705 3.356 2.016 0.793
Income/Loss From Continuing Operations Before Tax
53.36%
-135.77
-88.53 -89.23 -101.87 -96.49
Income Tax Expense/Benefit
180.88%
0.191
0.068 0.012 0.065 0.078
Income/Loss From Continuing Operations After Tax
53.46%
-135.96
-88.60 -89.24 -101.93 -96.56
Income/Loss From Discontinued Operations, Net Of Tax
93.47%
-0.103
-1.577 239.98 16.30 10.23
Net Income/Loss
50.89%
-136.06
-90.17 150.74 -85.63 -86.33
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
10,271%
77.14
0.7438 76.31 76.00 68.17
Diluted Average Shares
10,271%
77.14
0.7438 76.31 76.00 68.17
Basic Earnings Per Share
49.15%
-1.76
-1.18 1.97 -1.13 -1.27
Diluted Earnings Per Share
49.15%
-1.76
-1.18 1.97 -1.13 -1.27
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Capitalizzazione:     |  Volume (24 ore):